| 05 nov. 2019 | SALE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 242 | 8.83 USD | |
| 05 nov. 2019 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 695 | — | |
| 05 nov. 2019 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 695 | 0.00 USD | deriv |
| 18 sept. 2019 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 4 091 | — | |
| 18 sept. 2019 | SALE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 1 406 | 7.83 USD | |
| 18 sept. 2019 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 4 091 | 0.00 USD | deriv |
| 17 mars 2019 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 660 | — | |
| 18 mars 2019 | SALE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 230 | 16.63 USD | |
| 17 mars 2019 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 660 | 0.00 USD | deriv |
| 04 mars 2019 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 50 746 | 0.00 USD | deriv |
| 03 mars 2019 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 1 049 | — | |
| 04 mars 2019 | SALE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 363 | 16.88 USD | |
| 03 mars 2019 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 1 049 | 0.00 USD | deriv |
| 05 nov. 2018 | SALE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 346 | 22.73 USD | |
| 05 nov. 2018 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 695 | — | |
| 05 nov. 2018 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 695 | 0.00 USD | deriv |
| 17 mars 2018 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 660 | — | |
| 19 mars 2018 | SALE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 287 | 17.88 USD | |
| 17 mars 2018 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 660 | 0.00 USD | deriv |
| 03 mars 2018 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 1 049 | — | |
| 05 mars 2018 | TAX_WITHHOLDING | TEVA PHARMACEUTICAL INDUSTRIES LTD | 455 | 19.38 USD | |
| 03 mars 2018 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 1 049 | 0.00 USD | deriv |
| 09 févr. 2018 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 123 288 | 0.00 USD | deriv |
| 09 févr. 2018 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 48 361 | 0.00 USD | deriv |